日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of sodium-glucose cotransporter-2 inhibitors on aging biomarkers and plasma ceramide levels in type 2 diabetes: beyond glycemic control.

钠-葡萄糖协同转运蛋白-2抑制剂对2型糖尿病患者衰老生物标志物和血浆神经酰胺水平的影响:超越血糖控制

Shalaby Youssef M, Nakhal Mohammed Moutaz, Afandi Bachar, Al-Zohily Bashar, Majed Lina, Kumar Kukkala Kiran, Emerald Bright Starling, Sadek Bassem, Akour Amal, Akawi Nadia

A diagnostic RNA sequencing assay for direct identification and interpretation of pathogenic variants in the FBN1 gene

一种用于直接鉴定和解读FBN1基因致病变异的诊断性RNA测序检测方法

Irshaid, Manal; Al Mansoori, Ghadeera; Sulaiman, Mohamed; Mohamed, Asjed; Abdoh, Mohammed; Shalaby, Youssef M; Al-Zohily, Bashar; Batool, Aalia; Aleissaee, Sara; Alzyoud, Lara; Ali, Bassam R; Al Saffar, Muna; Akawi, Nadia

Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study.

靶向神经酰胺治疗早期心血管代谢脂毒性的体内研究及其治疗潜力。

Shalaby Youssef M, Al-Zohily Bashar, Sudhadev Manjusha, Nemmar Abderrahim, Al-Salam Suhail, Akawi Nadia

Circulating ceramide levels and ratios in Emirati youth under 18 years: associations with cardiometabolic risk factors

阿联酋18岁以下青少年循环神经酰胺水平和比值:与心血管代谢风险因素的关联

Shalaby, Youssef M; Al-Zohily, Bashar; Raj, Anjana; Yasin, Javed; Al Hamad, Sania; Antoniades, Charalambos; Akawi, Nadia; Aburawi, Elhadi H

Role of Ceramides in the Molecular Pathogenesis and Potential Therapeutic Strategies of Cardiometabolic Diseases: What we Know so Far

神经酰胺在心血管代谢疾病分子发病机制中的作用及潜在治疗策略:我们目前所了解的情况

Shalaby, Youssef M; Al Aidaros, Anas; Valappil, Anjana; Ali, Bassam R; Akawi, Nadia